JEAN JACQUES BIENAIME - 25 Mar 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
25 Mar 2025
Net transactions value
+$60,684
Form type
4
Filing time
26 Mar 2025, 16:05:21 UTC
Previous filing
25 Mar 2025
Next filing
03 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $60,684 +7,800 +33% $7.78 31,415 25 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction report was $7.78, and the range of prices were between $7.37 and $8.51, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.